Bostwick Labs Prepares For Public Stock Offering

CEO SUMMARY: In recent years, annual revenue at Bostwick Laboratories has skyrocketed, reaching $102.8 mil- lion in 2007. Now the company, known for its national uropathology expertise, has filed documents in preparation for an initial public stock offering (IPO). Bostwick Laboratories is the latest success story in anatomic pathology. It hopes to raise $100 million …

Bostwick Labs Prepares For Public Stock Offering Read More »

To access this post, you must purchase The Dark Report.

Bostwick Labs Prepares For Public Stock Offering

Noted uropathologist David G. Bostwick, M.D. is pathology’s newest successful entrepreneur

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month